ENTRY       D12199                      Drug
NAME        Plutavimab (USAN)
FORMULA     C6372H9888N1706O2007S46
EXACT_MASS  143891.1271
MOL_WEIGHT  143979.9071
SEQUENCE    (Heavy chain)
            EVQLVESGGG LIQPGGSLRL SCAASGFTVS SNYMSWVRQA PGKGLEWVSI IYPGGSTEYA
            DSVKGRFTIS RDNSRNTLYL QMNSLRAEDT AVYYCARELG YYGMDVWGQG TTVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKRVEPKSC DKTHTCPPCP APEAAGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIQMTQSPSS VSASVGDRVT ITCRASQGIS TWLVWYQQKP GKAPNLLIYG ASSLQSGVPS
            	RFSGSGSGTD FTLTISSLQP EDFATYYCQQ ANAYPYTFGQ GTKLEIKRTV
            AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD
            STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H220-L214, H144-H200, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'95, H'220-L'214, H'144-H'200, H'261-H'321, H'367-H'425, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of SARS-CoV-2 infection
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12199  Plutavimab
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12199  Plutavimab (USAN)
DBLINKS     CAS: 2529854-88-2
///
